The Consultant & Investment Group

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: JO3120711010
JOD
1.81
0.03 (1.69%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor Management Efficiency with a low ROCE of 5.67%

  • The company has been able to generate a Return on Capital Employed (avg) of 5.67% signifying low profitability per unit of total capital (equity and debt)
2

High Debt Company with a Debt to Equity ratio (avg) at times

3

Poor long term growth as Net Sales has grown by an annual rate of 11.95% and Operating profit at 39.42% over the last 5 years

 
4

Negative results in Dec 25

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Miscellaneous

stock-summary
Market cap

JOD 36 Million (Small Cap)

stock-summary
P/E

18.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.23

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
7 Million
(Quarterly Results - Dec 2025)
Net Profit:
0 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.56%
0%
0.56%
6 Months
0.56%
0%
0.56%
1 Year
-9.05%
0%
-9.05%
2 Years
-7.65%
0%
-7.65%
3 Years
13.12%
0%
13.12%
4 Years
44.8%
0%
44.8%
5 Years
-1.0%
0%
-1.0%

The Consultant & Investment Group for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
11.95%
EBIT Growth (5y)
39.42%
EBIT to Interest (avg)
1.31
Debt to EBITDA (avg)
0.80
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
3.20
Tax Ratio
14.78%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.67%
ROE (avg)
4.36%

Valuation key factors

Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
1.46
EV to EBIT
14.75
EV to EBITDA
9.26
EV to Capital Employed
1.36
EV to Sales
1.76
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.22%
ROE (Latest)
8.17%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 3.03% vs 6.45% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -16.67% vs 0.00% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6.80",
          "val2": "6.60",
          "chgp": "3.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.70",
          "val2": "1.40",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.20",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.50",
          "val2": "0.60",
          "chgp": "-16.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "108.80%",
          "val2": "142.40%",
          "chgp": "-3.36%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 12.00% vs 16.58% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 50.00% vs 75.00% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "25.20",
          "val2": "22.50",
          "chgp": "12.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.60",
          "val2": "4.00",
          "chgp": "-10.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.00",
          "val2": "0.80",
          "chgp": "25.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.40",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.10",
          "val2": "1.40",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "141.80%",
          "val2": "107.40%",
          "chgp": "3.44%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
6.80
6.60
3.03%
Operating Profit (PBDIT) excl Other Income
0.70
1.40
-50.00%
Interest
0.30
0.20
50.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.50
0.60
-16.67%
Operating Profit Margin (Excl OI)
108.80%
142.40%
-3.36%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 3.03% vs 6.45% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -16.67% vs 0.00% in Sep 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
25.20
22.50
12.00%
Operating Profit (PBDIT) excl Other Income
3.60
4.00
-10.00%
Interest
1.00
0.80
25.00%
Exceptional Items
0.00
-0.40
100.00%
Consolidate Net Profit
2.10
1.40
50.00%
Operating Profit Margin (Excl OI)
141.80%
107.40%
3.44%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 12.00% vs 16.58% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 50.00% vs 75.00% in Dec 2024

stock-summaryCompany CV
About The Consultant & Investment Group stock-summary
stock-summary
The Consultant & Investment Group
Miscellaneous
Consultant and Investment Group Company Psc is a Jordan-based public shareholding company, which is engaged in the healthcare and medical sector. The Company operates through managing and operating healthcare facilities and projects such as hospitals and clinics. Consulting and Investment Company Group PSC manages and operates Istishari Hospital, which is located in Amman, Jordan, and provides diagnostic and treatment options, as well as personalized patient care and service, among other related facilities. Its clinical services include: anesthesia, dental, endocrinology, family medicine, gastroenterology, hepatology, infections and tropical, diseases, neurology, orthopedics, pediatrics and primary care. Its medical services include: inpatient accommodations, intensive care unit, neonatal intensive care unit and operating theaters.
Company Coordinates stock-summary
Company Details
King Abdullah Gardens Cross, Wadi Saqrah,, P.O.Box 840431, AMMAN None : 11184
Registrar Details